BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28891101)

  • 1. The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.
    Prasad JD; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Lake F; Hopkins PMA; Corte TJ; Allan H; Glaspole IN
    Respirology; 2017 Oct; 22(7):1459-1472. PubMed ID: 28891101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres.
    Jo HE; Corte TJ; Moodley Y; Levin K; Westall G; Hopkins P; Chambers D; Glaspole I
    BMC Pulm Med; 2016 Feb; 16():22. PubMed ID: 26831722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.
    Jo HE; Troy LK; Keir G; Chambers DC; Holland A; Goh N; Wilsher M; de Boer S; Moodley Y; Grainge C; Whitford H; Chapman S; Reynolds PN; Glaspole I; Beatson D; Jones L; Hopkins P; Corte TJ
    Respirology; 2017 Oct; 22(7):1436-1458. PubMed ID: 28845557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.
    Jee AS; Sheehy R; Hopkins P; Corte TJ; Grainge C; Troy LK; Symons K; Spencer LM; Reynolds PN; Chapman S; de Boer S; Reddy T; Holland AE; Chambers DC; Glaspole IN; Jo HE; Bleasel JF; Wrobel JP; Dowman L; Parker MJS; Wilsher ML; Goh NSL; Moodley Y; Keir GJ
    Respirology; 2021 Jan; 26(1):23-51. PubMed ID: 33233015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.
    Jo HE; Prasad JD; Troy LK; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Holland AE; Lake FR; Keir G; Goh NS; Wilsher M; de Boer S; Moodley Y; Grainge C; Whitford HM; Chapman SA; Reynolds PN; Beatson D; Jones LJ; Hopkins P; Allan HM; Glaspole I; Corte TJ
    Med J Aust; 2018 Feb; 208(2):82-88. PubMed ID: 29385965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey.
    Sharp C; Maher TM; Welham S; Gibbons M
    Thorax; 2015 Feb; 70(2):183. PubMed ID: 25352531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of the interstitial lung disease multidisciplinary service.
    Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
    Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
    Mackintosh JA; Keir G; Troy LK; Holland AE; Grainge C; Chambers DC; Sandford D; Jo HE; Glaspole I; Wilsher M; Goh NSL; Reynolds PN; Chapman S; Mutsaers SE; de Boer S; Webster S; Moodley Y; Corte TJ
    Respirology; 2024 Feb; 29(2):105-135. PubMed ID: 38211978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
    Bradley B; Branley HM; Egan JJ; Greaves MS; Hansell DM; Harrison NK; Hirani N; Hubbard R; Lake F; Millar AB; Wallace WA; Wells AU; Whyte MK; Wilsher ML; ; ; ;
    Thorax; 2008 Sep; 63 Suppl 5():v1-58. PubMed ID: 18757459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current classification of interstitial pulmonary diseases].
    Vogel-Claussen J; Prasse A
    Radiologe; 2014 Dec; 54(12):1147-52. PubMed ID: 25432870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unclassifiable interstitial lung disease: A review.
    Skolnik K; Ryerson CJ
    Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.
    Jacobs SS; Krishnan JA; Lederer DJ; Ghazipura M; Hossain T; Tan AM; Carlin B; Drummond MB; Ekström M; Garvey C; Graney BA; Jackson B; Kallstrom T; Knight SL; Lindell K; Prieto-Centurion V; Renzoni EA; Ryerson CJ; Schneidman A; Swigris J; Upson D; Holland AE
    Am J Respir Crit Care Med; 2020 Nov; 202(10):e121-e141. PubMed ID: 33185464
    [No Abstract]   [Full Text] [Related]  

  • 13. Interstitial lung disease in 2015: where are we now?
    Troy L; Corte T
    Aust Fam Physician; 2015 Aug; 44(8):546-52. PubMed ID: 26510140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing interstitial lung disease by multidisciplinary discussion: A review.
    Glenn LM; Troy LK; Corte TJ
    Front Med (Lausanne); 2022; 9():1017501. PubMed ID: 36213664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.
    Kurland G; Deterding RR; Hagood JS; Young LR; Brody AS; Castile RG; Dell S; Fan LL; Hamvas A; Hilman BC; Langston C; Nogee LM; Redding GJ;
    Am J Respir Crit Care Med; 2013 Aug; 188(3):376-94. PubMed ID: 23905526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survey of Specialist Pulmonary Medicine Health Care Structures for Patients with Interstitial Lung Disease in Nordrhein-Westfalen, Germany - A Pilot Project of the Western German Respiratory Society (WdGP)].
    Hagmeyer L; Haidl P; Westhoff M; Schulte W; Randerath W; Lorenz J
    Pneumologie; 2018 Jul; 72(7):523-530. PubMed ID: 29788515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease international guidelines.
    Fabbri L; Caramori G; Beghe B; Papi A; Ciaccia A
    Curr Opin Pulm Med; 1998 Mar; 4(2):76-84. PubMed ID: 9612669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unclassifiable interstitial lung disease: from phenotyping to possible treatments.
    Guler SA; Ryerson CJ
    Curr Opin Pulm Med; 2018 Sep; 24(5):461-468. PubMed ID: 30004990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and Treatment of Interstitial Lung Diseases].
    Jakubczyc A; Neurohr C
    Dtsch Med Wochenschr; 2018 Dec; 143(24):1774-1777. PubMed ID: 30508858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
    Walsh SLF; Wells AU; Desai SR; Poletti V; Piciucchi S; Dubini A; Nunes H; Valeyre D; Brillet PY; Kambouchner M; Morais A; Pereira JM; Moura CS; Grutters JC; van den Heuvel DA; van Es HW; van Oosterhout MF; Seldenrijk CA; Bendstrup E; Rasmussen F; Madsen LB; Gooptu B; Pomplun S; Taniguchi H; Fukuoka J; Johkoh T; Nicholson AG; Sayer C; Edmunds L; Jacob J; Kokosi MA; Myers JL; Flaherty KR; Hansell DM
    Lancet Respir Med; 2016 Jul; 4(7):557-565. PubMed ID: 27180021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.